The in vitro and in vivo effect of a chemokine inhibitor CTCE-9908 in combination with Kynurenine metabolites on tumour adhesion by Danielle Tatchum (16946574)

“…In the non-cancerous cell lines HaCaT and EA. hy926, there was a decrease in percentage cell number after treatment with L-kyn, phorbol 12-myristate 13-acetate (PMA), a positive control for adhesion, and CTCE-9908, suggesting a decrease in cell adhesion in the non-cancerous cell lines.…”

Cervical Cancer Screening in Partly HPV Vaccinated Cohorts – A Cost-Effectiveness Analysis by Steffie K. Naber (2175986)

“…</p><p>Methods</p><p>We used the MISCAN-Cervix model to determine the optimal screening strategy for a pre-vaccination population and for vaccinated women (~80% decreased risk), assuming a willingness-to-pay of €50,000 per quality-adjusted life year gained. …”

Joey Tan: The role of preptin in the response of bone tissue to a high-fat diet by Joey Tan (11499238)

Whole body glucose metabolism and insulin secretion in KO mice. by Yasutaka Miyachi (3178986)

Evaluation of developmental toxicity and teratogenicity. by Shen Huang (9967526)

RICTOR silencing inhibits cell proliferation via UGCG regulation. by Mohammad Nafees Ansari (22232505)

“…(<b>F</b>) Fold change (mean ± SEM, <i>n</i> = 5) in different sphingolipid species reveals an increase in ceramides and a decrease in glucosylceramides in MCF-7_RICTOR^SH cells compared to MCF-7 cells. …”

DNA double strand break levels increase with age in <i>fog-2</i> feminized germlines. by Erik Toraason (5724689)

Fig 3 - by Sara Hintze (3216885)

Effects of bortezomib on total OATP1B1 and OATP1 B3 protein levels and total ubiquitin-conjugated proteins in human SCH. by Khondoker Alam (1443499)

Total lipid contents of ovaries from queens sampled at different seasonal time points. by Mark J. Carroll (3605582)

Percentage of living PC3 cells in presence of DRS-B2 and sodium chlorate. by Célia Dos Santos (306471)

Effects of lysosome inhibitor chloroquine on total protein levels of OATP1B3 in HEK293-OATP1B3 cells and human SCH. by Khondoker Alam (1443499)

Measurements of body mass index (BMI) and adipose deposits. by Jessica C. M. Hui (20370522)

Effect of cGAS deficiency on picornaviruses replication <i>in vitro</i>. by Huisheng Liu (408091)

A. We randomly selected 20 mutually exclusive groups of protein complexes that contained exactly five subunits; we mapped the corresponding gene pairs to SINaTRA scores, and plotte... by Alexandra Jacunski (5665486)

“…We compared the fraction of gene pairs with products in the same vs. different complexes for three SINaTRA cutoffs (0.95, 0.80, 0.50) as well as for all gene pairs. A SINaTRA cutoff of 0.95 has approximately half of its pairs associated with the same complex; however, a decrease in the cutoff shifts this balance. …”

Data_Sheet_1_Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the double-blind, randomized, placebo-controlled CORVETTE-01 trial.docx by Tatsuhiko Wada (14391781)

“…</p>Results<p>Overall, 112 and 109 patients were randomized to ivermectin and placebo, respectively; 106 patients from each group were included in the full analysis set (male [%], mean age: 68.9%, 47.9 years [ivermectin]; 62.3%, 47.5 years [placebo]). …”

Data_Sheet_1_Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the double-blind, randomized, placebo-controlled CORVETTE-01 trial.docx by Tatsuhiko Wada (14391781)

“…</p>Results<p>Overall, 112 and 109 patients were randomized to ivermectin and placebo, respectively; 106 patients from each group were included in the full analysis set (male [%], mean age: 68.9%, 47.9 years [ivermectin]; 62.3%, 47.5 years [placebo]). …”

Data_Sheet_1_Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the double-blind, randomized, placebo-controlled CORVETTE-01 trial.docx by Tatsuhiko Wada (14391781)

“…</p>Results<p>Overall, 112 and 109 patients were randomized to ivermectin and placebo, respectively; 106 patients from each group were included in the full analysis set (male [%], mean age: 68.9%, 47.9 years [ivermectin]; 62.3%, 47.5 years [placebo]). …”

Receiver position and time error applying range difference method. by Jae Hwan Bong (17054738)

Transition matrix of LULC change (ha) between 1999 and 2009. by Ajit Kumar Rudra (21647706)